Welcome to LookChem.com Sign In|Join Free

CAS

  • or

17071-24-8

Post Buying Request

17071-24-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

17071-24-8 Usage

General Description

Ethanone, 1-(3-amino-4-methylphenyl)- (9CI) is a chemical compound that is also known by the name 1-(3-Amino-4-methylphenyl)ethan-1-one. It is a ketone compound with the molecular formula C9H11NO and a molecular weight of 149.19 g/mol. Ethanone, 1-(3-amino-4-methylphenyl)- (9CI) is characterized by its aromatic structure and consists of a phenyl ring attached to a carbon atom, which is further connected to an amine group and a methyl group. The compound may have applications in organic synthesis and pharmaceutical research due to its unique chemical structure and potential reactivity. However, further research and testing may be necessary to fully understand its specific properties and potential uses.

Check Digit Verification of cas no

The CAS Registry Mumber 17071-24-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,0,7 and 1 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 17071-24:
(7*1)+(6*7)+(5*0)+(4*7)+(3*1)+(2*2)+(1*4)=88
88 % 10 = 8
So 17071-24-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H11NO/c1-6-3-4-8(7(2)11)5-9(6)10/h3-5H,10H2,1-2H3

17071-24-8Relevant articles and documents

Tariquidar-Related Chalcones and Ketones as ABCG2 Modulators

Pe?a-Solórzano, Diana,Scholler, Matthias,Bernhardt, Günther,Buschauer, Armin,K?nig, Burkhard,Ochoa-Puentes, Cristian

, p. 854 - 859 (2018)

ABC transporters, including ABCG2, play a vital role in defending the human body against the vast range of xenobiotics. Even though this is beneficial for human health, these protein transporters have been implicated in the emerging resistance of cancer c

THIAZOLIDINONE COMPOUNDS AND USE THEREOF

-

Paragraph 0243-0244, (2017/09/21)

A pharmaceutical composition containing a compound of Formula (I) for treating an opioid receptor-associated condition. Also disclosed is a method for treating an opioid receptor-associated condition using such a compound. Further disclosed are two sets of thiazolidinone compounds of formula (I): (i) compounds each having an enantiomeric excess greater than 90% and (ii) compounds each being substituted with deuterium.

Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors

Murray, Christopher W.,Berdini, Valerio,Buck, Ildiko M.,Carr, Maria E.,Cleasby, Anne,Coyle, Joseph E.,Curry, Jayne E.,Day, James E. H.,Day, Phillip J.,Hearn, Keisha,Iqbal, Aman,Lee, Lydia Y. W.,Martins, Vanessa,Mortenson, Paul N.,Munck, Joanne M.,Page, Lee W.,Patel, Sahil,Roomans, Susan,Smith, Kirsten,Tamanini, Emiliano,Saxty, Gordon

supporting information, p. 798 - 803 (2015/07/15)

The DDR1 and DDR2 receptor tyrosine kinases are activated by extracellular collagen and have been implicated in a number of human diseases including cancer. We performed a fragment-based screen against DDR1 and identified fragments that bound either at th

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17071-24-8